Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19670 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Barbora Weinbergerová und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine - Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Bridged Bicyclo Compounds, Heterocyclic, Azacitidine, Sulfonamides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute for Cancer Research Project, EuropeanUnion-Next Generation EU, Czech Leukemia Study Group for Life (CELL).
Abstract (Originalsprache)
Our observational study analysed fungal infection frequency within cohorts with versus without antifungal prophylaxis (AFP) among newly diagnosed first‐line venetoclax and azacitidine (VEN + AZA)‐treated acute myeloid leukaemias in Czech, Austrian and Slovak haematology centres. Among 186 patients, 85 (46%) received antifungal prophylaxis, while 101 (54%) received no prophylaxis. Fungal infections occurred in 1/85 patients with prophylaxis (1%) and 5/101 patients without prophylaxis (5%) ( p = 0.222). No significant difference was recorded between cohorts with and without AFP in terms of death rate ( p = 0.296) and overall survival ( p = 0.844). In conclusion, most infections were not severe, developing during the first treatment‐cycle and did not affect patients' overall outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine - Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
- Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
- Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
- 4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- Medical Department, Hematology, Charles University General Hospital, Prague, Czech Republic.
- Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
ORCID-Profile: Barbora Weinbergerová
Förderung
- National Institute for Cancer Research Project
- EuropeanUnion-Next Generation EU
- Czech Leukemia Study Group for Life (CELL)
- Cellulose and Renewable Materials Division of the American Chemical Society
Zitieren
APA
Weinbergerová, B., Mayer, J., Kabut, T., Sperr, W. R., Števková, J., Jonášová, A., Čerňan, M., Herndlhofer, S., Oravcová, I., Šrámek, J., Novák, J., Štěpánová, R., Szotkowski, T., Drgoňa, L., Žák, P., & Valent, P. (2024). Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. British Journal of Haematology. https://doi.org/10.1111/bjh.19670
Vancouver
Weinbergerová B, Mayer J, Kabut T, Sperr WR, Števková J, Jonášová A, et al. Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. British Journal of Haematology. 2024. doi:10.1111/bjh.19670
BibTeX
@article{Weinbergerov2024,
author = {Weinbergerová, Barbora and Mayer, Jiří and Kabut, Tomáš and Sperr, Wolfgang R and Števková, Jana and Jonášová, Anna and Čerňan, Martin and Herndlhofer, Susanne and Oravcová, Iveta and Šrámek, Jiří and Novák, Jan and Štěpánová, Radka and Szotkowski, Tomáš and Drgoňa, Luboš and Žák, Pavel and Valent, Peter},
title = {Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19670}
}
EUVIMED